Holen Sie sich die Stockscreener-App
15.36
1.92%
0.29
Handel nachbörslich:
15.21
-0.15
-0.98%
Schlusskurs vom Vortag:
$15.07
Offen:
$15.1
24-Stunden-Volumen:
97,144
Relative Volume:
0.07
Marktkapitalisierung:
$151.42M
Einnahmen:
$88.50M
Nettoeinkommen (Verlust:
$-35.27M
KGV:
-4.661
EPS:
-3.2954
Netto-Cashflow:
$-23.70M
1W Leistung:
+11.39%
1M Leistung:
-18.21%
6M Leistung:
+103.71%
1J Leistung:
+34.64%
1-Tages-Spanne:
$15.10
$16.26
1-Wochen-Bereich:
$13.58
$16.26
52-Wochen-Spanne:
$3.436
$20.21
Biodesix Inc Stock (BDSX) Company Profile
Firmenname
Biodesix Inc
Sektor
Branche
Telefon
303-417-0500
Adresse
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
15.36 | 148.57M | 88.50M | -35.27M | -23.70M | -3.2954 |
TMO
Thermo Fisher Scientific Inc
|
488.19 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
192.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
577.44 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.84 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.09 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-27 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-05-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-07-26 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-13 | Eingeleitet | TD Cowen | Buy |
| 2024-05-03 | Eingeleitet | Lake Street | Buy |
| 2021-11-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | Eingeleitet | BTIG Research | Buy |
| 2020-11-23 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-23 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-23 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Biodesix Inc Aktie (BDSX) Neueste Nachrichten
Biodesix Unveils Novel Diagnostic Test at AACR 2026 - National Today
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development - The Manila Times
Biodesix to Showcase Advances in Diagnostic Solutions at AACR Annual Meeting 2026 - Quiver Quantitative
Cancer test developer Biodesix brings 7 studies to AACR meeting - stocktitan.net
Energy Moves: Can Biodesix Inc expand into new markets2026 Big Picture & Precise Buy Zone Identification - baoquankhu1.vn
BDSX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Biodesix (BDSX) chair adds 1,361 shares through RSU exercise - stocktitan.net
Allworth Financial LP Reduces Holdings in Biodesix, Inc. $BDSX - marketbeat.com
Biodesix, Inc. (NASDAQ:BDSX) Given Average Recommendation of "Moderate Buy" by Brokerages - marketbeat.com
Wall Street analysts see an 86.45% upside in Biodesix (BDSX): Can the stock really move this high? - MSN
AI Stocks: Can Biodesix Inc expand into new marketsMarket Growth Review & Technical Entry and Exit Tips - baoquankhu1.vn
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Down 19.4% in March - marketbeat.com
Weekly Earnings: What is the dividend yield of Biodesix IncQuarterly Portfolio Review & Daily Growth Stock Tips - baoquankhu1.vn
BDSX Stock Price, Quote & Chart | BIODESIX INC (NASDAQ:BDSX) - ChartMill
$Biodesix (BDSX.US)$ I am out - moomoo.com
Is Biodesix (BDSX) stock outpacing its medical peers this year? - MSN
If You Invested $1,000 in BIODESIX INC (BDSX) - stocktitan.net
Biodesix publishes lung nodule biomarker validation study By Investing.com - Investing.com Australia
Biodesix, Inc.Common Stock (NQ: BDSX - The Chronicle-Journal
Biodesix publishes lung nodule biomarker validation study on 1,100 patients - Investing.com
Biodesix publishes lung nodule biomarker validation study - Investing.com
Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis - The Manila Times
Biodesix Publishes Largest Lung Nodule Biomarker Study, Validating Nodify CDT® Test for Lung Cancer Risk Assessment - Quiver Quantitative
Study of 1,100 patients backs blood test for earlier lung cancer diagnosis - Stock Titan
Is Biodesix (BDSX) Shares Performing Better Than Other Medical Stocks This Year? - Bitget
Wall Street Analysts See an 86.45% Upside in Biodesix (BDSX): Can the Stock Really Move This High? - Yahoo Finance
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Is Biodesix (BDSX) Shares Surpassing Other Medical Stocks This Year? - Bitget
Treasury Yields: Can Biodesix Inc navigate macro headwinds2026 Pullbacks & Comprehensive Market Scan Insights - baoquankhu1.vn
Biodesix, Inc. (BDSX) reports Q4 loss, beats revenue estimates - MSN
Wall Street analysts think Biodesix (BDSX) could surge 111.62%: Read this before placing a bet - MSN
Decliners Report: Is Biodesix Inc benefiting from innovation trends2026 Pullbacks & Verified Momentum Stock Alerts - baoquankhu1.vn
Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript - MSN
Cannell & Spears LLC Sells 195,326 Shares of Biodesix, Inc. $BDSX - MarketBeat
Biodesix Details Lung Test Momentum, 81% Gross Margin and Growth Plan at Barclays Conference - marketbeat.com
Recap Report: What is the dividend yield of Biodesix IncNew Guidance & Accurate Trade Setup Notifications - baoquankhu1.vn
BDSX SEC FilingsBIODESIX INC 10-K, 10-Q, 8-K Forms - stocktitan.net
Biodesix Receives 'Moderate Buy' Rating from Analysts - National Today
Biodesix at Barclays Conference: Strategic Growth in Lung Cancer Diagnostics - Investing.com Canada
Biodesix Earnings Call Signals Growth With Caveats - TipRanks
Setup Watch: Is Biodesix Inc in a consolidation phase2026 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Biodesix Details Lung Nodule Growth Plan, Primary Care Push at TD Cowen Healthcare Conference - MarketBeat
What analysts say about Biodesix Inc stock2025 Dividend Review & Daily Stock Momentum Reports - baoquankhu1.vn
How The Biodesix (BDSX) Investment Story Is Shifting After Guidance And New US$30 Target - Yahoo Finance
Wall Street experts predict that Biodesix (BDSX) may climb by 111.62%: Consider this information before making an investment decision - Bitget
Wall Street Analysts Think Biodesix (BDSX) Could Surge 111.62%: Read This Before Placing a Bet - Finviz
Are Medical Stocks Lagging Biodesix (BDSX) This Year? - Yahoo Finance
BDSX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Finanzdaten der Biodesix Inc-Aktie (BDSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
1.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):